Compounds > etoposide
Page last updated: 2024-08-23

etoposide and Mixed Tumor, Mullerian

etoposide has been researched along with Mixed Tumor, Mullerian in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Carcangiu, ML; Chambers, JT; Chambers, SK; Kohorn, EI; Resnik, E; Schwartz, PE1
Carcangiu, ML; Cass, I; Chambers, JT; Chambers, SK; Kohorn, EI; Resnik, E; Schwartz, PE1

Trials

1 trial(s) available for etoposide and Mixed Tumor, Mullerian

ArticleYear
A phase II study of etoposide, cisplatin, and doxorubicin chemotherapy in mixed müllerian tumors (MMT) of the uterus.
    Gynecologic oncology, 1995, Volume: 56, Issue:3

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Middle Aged; Mixed Tumor, Mullerian; Neoplasm Staging; Survival Rate; Uterine Neoplasms

1995

Other Studies

1 other study(ies) available for etoposide and Mixed Tumor, Mullerian

ArticleYear
Combination chemotherapy with etoposide, cisplatin, and doxorubicin in mixed müllerian tumors of the adnexa.
    Gynecologic oncology, 1996, Volume: 61, Issue:3

    Topics: Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Doxorubicin; Etoposide; Fallopian Tube Neoplasms; Female; Humans; Middle Aged; Mixed Tumor, Mullerian; Ovarian Neoplasms; Survival Analysis; Treatment Outcome

1996